Security Snapshot

Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY) Institutional Ownership

CUSIP: 86881A100

13F Institutional Holders and Ownership History from Q4 2015 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

177

Shares (Excl. Options)

157,071,902

Price

$11.92

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
SGRY on Nasdaq
Shares outstanding
130,463,918
Price per share
$13.87
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
157,071,902
Total reported value
$1,872,274,727
% of total 13F portfolios
0%
Share change
+935,922
Value change
+$4,510,508
Number of holders
177
Price from insider filings
$13.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SGRY - Surgery Partners, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 86881A100.
  • 177 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 179 to 177 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,423,515,290 to $1,872,274,727.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 177 institutions filings for Q1 2026.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 86881A100?
CUSIP 86881A100 identifies SGRY - Surgery Partners, Inc. - Common Stock, par value $0.01 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.

Significant Owners of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BCPE Seminole Holdings LP 23% -0.62% $687,963,459 30,055,197 0% BCPE Seminole Holdings II Intermediate, LP 16 Jun 2025
JANUS HENDERSON GROUP PLC 10% +1% $282,111,656 +$1,767,274 13,036,583 +0.63% JANUS HENDERSON GROUP PLC 30 Sep 2025
Pentwater Capital Management LP 9.7% +25% $165,653,950 +$34,753,950 12,655,000 +27% Pentwater Capital Management LP 31 Mar 2026
KING STREET CAPITAL MANAGEMENT, L.P. 7.2% $202,116,085 9,339,930 King Street Capital Management, L.P. 30 Oct 2025
BlackRock, Inc. 4.4% $126,722,839 5,675,004 BlackRock, Inc. 31 Mar 2025
FMR LLC 1.7% -68% $28,686,278 -$56,883,263 2,191,465 -66% FMR LLC 31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP 0% -93% $4,783 -$156,297,520 217 -100% Wellington Management Group LLP 30 Jun 2025

As of 31 Mar 2026, 177 institutional investors reported holding 157,071,902 shares of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY). This represents 120% of the company’s total 130,463,918 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY) together control 109% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bain Capital Investors LLC 38% 49,946,972 0% 18% $595,367,906
JANUS HENDERSON GROUP PLC 10% 13,540,385 +0.02% 0.08% $161,400,529
Pentwater Capital Management LP 9.7% 12,655,000 +27% 1.1% $150,847,600
KING STREET CAPITAL MANAGEMENT, L.P. 7.8% 10,229,730 0% 37% $121,938,382
UBS Group AG 7.8% 10,191,781 +31% 0.02% $121,486,029
BlackRock, Inc. 4.3% 5,660,788 -0.53% 0% $67,476,592
DIMENSIONAL FUND ADVISORS LP 4.1% 5,296,411 +7.9% 0.01% $63,130,850
Clearbridge Investments, LLC 3.2% 4,118,056 -2.6% 0.04% $49,087,222
VANGUARD PORTFOLIO MANAGEMENT LLC 2.8% 3,628,431 0% 0% $43,250,898
VANGUARD CAPITAL MANAGEMENT LLC 2.6% 3,430,795 0% 0% $40,895,076
Davidson Kempner Capital Management LP 2.6% 3,336,464 +41% 0.86% $39,770,651
FMR LLC 1.7% 2,191,465 -67% 0% $26,122,264
GEODE CAPITAL MANAGEMENT, LLC 1.5% 2,002,374 +3% 0% $23,872,449
STATE STREET CORP 1.5% 1,953,778 +4.3% 0% $23,289,034
T. Rowe Price Investment Management, Inc. 1.5% 1,949,720 +311% 0.02% $23,241,000
HSBC HOLDINGS PLC 1.5% 1,915,668 -0.82% 0.01% $22,567,082
GLENVIEW CAPITAL MANAGEMENT, LLC 1.4% 1,800,000 -53% 0.58% $21,456,000
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.2% 1,589,368 +44% 0% $18,945,266
GOLDMAN SACHS GROUP INC 0.98% 1,280,552 -35% 0% $15,264,180
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.85% 1,107,250 +12% 0% $13,198,420
LMR Partners LLP 0.84% 1,100,000 +205% 0.12% $13,112,000
Sea Cliff Partners Management, LP 0.8% 1,039,799 +54% 6.4% $12,394,404
MORGAN STANLEY 0.78% 1,012,177 -11% 0% $12,065,151
Man Group plc 0.73% 946,519 +188% 0.02% $11,282,506
Whitefort Capital Management, LP 0.7% 911,136 +52% 3.3% $10,860,741

Institutional Holders of Surgery Partners, Inc. - Common Stock, par value $0.01 per share (SGRY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 157,071,902 $1,872,274,727 +$4,510,508 $11.92 177
2025 Q4 156,841,353 $2,423,515,290 +$56,378,763 $15.45 179
2025 Q3 151,406,137 $3,276,548,227 +$150,915,327 $21.64 197
2025 Q2 144,278,301 $3,207,216,275 +$96,557,278 $22.23 197
2025 Q1 139,643,559 $3,318,979,664 -$12,576,150 $23.75 204
2024 Q4 141,590,930 $2,997,289,879 +$19,892,991 $21.17 179
2024 Q3 137,923,250 $4,445,824,164 -$93,744,817 $32.24 184
2024 Q2 141,883,973 $3,375,681,923 +$113,712,319 $23.79 176
2024 Q1 136,901,931 $4,083,856,130 +$38,695,342 $29.83 178
2023 Q4 135,040,344 $4,320,033,899 +$5,014,626 $31.99 173
2023 Q3 134,819,136 $3,943,422,688 +$14,620,005 $29.25 164
2023 Q2 132,665,983 $5,968,815,677 +$151,844,535 $44.99 166
2023 Q1 130,043,383 $4,482,475,885 +$52,737,369 $34.47 151
2022 Q4 128,874,004 $3,590,376,282 +$982,835,667 $27.86 158
2022 Q3 93,927,789 $2,198,657,234 +$8,876,623 $23.40 130
2022 Q2 92,368,659 $2,671,774,444 +$36,680,603 $28.92 131
2022 Q1 90,688,899 $4,990,971,268 +$127,182,466 $55.05 142
2021 Q4 88,382,048 $4,720,313,294 +$406,797,201 $53.41 133
2021 Q3 81,052,523 $3,431,762,979 +$5,393,826 $42.34 133
2021 Q2 80,625,719 $5,370,104,650 +$1,564,829,794 $66.62 134
2021 Q1 57,619,712 $2,550,066,106 +$478,555,256 $44.26 119
2020 Q4 47,610,695 $1,381,528,968 -$18,908,903 $29.01 114
2020 Q3 47,513,254 $1,040,400,198 +$2,262,549 $21.90 99
2020 Q2 48,235,131 $557,972,424 +$27,624,491 $11.57 97
2020 Q1 46,997,441 $306,469,825 -$2,816,295 $6.53 83
2019 Q4 45,555,720 $715,530,434 -$26,037,507 $15.65 96
2019 Q3 47,534,648 $351,174,009 -$360,668 $7.38 85
2019 Q2 47,665,322 $387,959,241 -$59,203 $8.14 89
2019 Q1 47,815,066 $539,355,255 +$3,158,341 $11.28 79
2018 Q4 47,570,471 $465,711,541 -$7,762,616 $9.79 79
2018 Q3 47,408,913 $782,246,275 -$2,998,520 $16.50 78
2018 Q2 47,697,157 $710,694,056 -$6,654,865 $14.90 81
2018 Q1 48,029,358 $823,698,997 -$18,384,290 $17.15 80
2017 Q4 49,397,866 $597,717,238 +$37,469,838 $12.10 82
2017 Q3 46,315,129 $479,287,393 +$237,951,990 $10.35 88
2017 Q2 18,654,721 $424,409,724 -$4,197,428 $22.75 87
2017 Q1 18,970,601 $369,720,474 +$43,505,768 $19.50 84
2016 Q4 18,110,074 $287,048,179 -$13,797,345 $15.85 89
2016 Q3 18,657,986 $377,631,305 -$19,731,223 $20.24 84
2016 Q2 18,594,156 $332,832,883 +$30,979,903 $17.90 83
2016 Q1 17,330,334 $229,805,000 +$10,525,960 $13.26 62
2015 Q4 16,268,455 $333,415,137 +$333,382,137 $20.49 59
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .